Mylan

Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
Magazine

Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive

By
December 6, 2021
The drug giant will merge its off-patent unit with generic drug company Mylan.
Health

Generic Drug Industry Sees New Giant as Pfizer Merges Off-Patent Unit With Mylan

By Timothy Annett, Riley Ray Griffin and Bloomberg
July 29, 2019
EpiPen shortage Walgreens Auvi-Q
Health

There’s Still a Big EpiPen Shortage—But Walgreens Will Start Selling a Competing Product

By
September 7, 2018
FDA EpiPen generic
Health

The FDA Finally Approved an EpiPen Generic. But a Shortage Looms Ahead of the School Year

By
August 16, 2018
Mylan Buys Abbott Laboratories Generic Drug Business For $5.3 Billion
Health

Mylan Is Surging and Teva Is Slumping After the FDA Okayed This New Drug

By
October 4, 2017
Protestors Rally In New York Against EipPen Price Gouging Scandal
Retail

Investors Are Calling on Mylan’s Chairman and Director to Step Down

By
June 29, 2017
House Oversight Committee Holds Hearing On Rising Price Of EpiPens With Mylan Inc. CEO Heather Bresch
Health

EpiPen Maker Mylan Saves Millions in Taxes Thanks to Huge Stakes in Coal Companies

By
June 21, 2017
Mylan NV EpiPen 2-Pak medication sits on a table inside a pharmacy in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.
Health

Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan?

By
June 19, 2017
Pharmaceutical Drug Roundup Inside A Pharmacy
Health

Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages

By
June 13, 2017
Robert J. Coury, vice chairman and chief executive officer o
Health

Mylan’s Shareholders Fight to Dump Its Board After the Epipen Scandal

By
May 31, 2017
Global Pharmaceuticals Brands
Finance

Mylan’s EpiPen Recall Couldn’t Come at a Worse Time

By
April 3, 2017
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Health

Mylan’s Massive Recall of Faulty EpiPens Spreads to the U.S.

By
April 1, 2017
FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
Health

FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug

By
March 30, 2017
Mylan NVs EpiPen Product Illustrations As Company's Move to Curb EpiPen Costs Blasted as PR Fix by Congress
Health

Mylan Recalls 81,000 EpiPens Outside U.S. After Reports of Failure

By
March 23, 2017
A file photo showing the EpiPen auto-injection epinephrine pens manufactured by Mylan NV pharmaceutical company are seen in Washington
Health

Mylan’s EpiPen Is Bleeding Market Share to Its Rivals

By
March 6, 2017

Most Popular